期刊文献+

无水乙醇在原发性肝癌合并门静脉癌栓经导管动脉栓塞术中的应用价值 被引量:4

Appilcation value and clinical curative effectiveness of ethanol in transcatheter arterial embolization for hepatocllular carcinoma(HCC) with portal vein tumor thrombus
暂未订购
导出
摘要 目的:回顾性研究超选择性门静脉癌栓(Protal vein tumor thrombus,PVTT)滋养动脉内注射无水乙醇及主癌灶超选择性完全性供瘤动脉栓塞的疗效,评价无水乙醇在局部治疗中的作用,以期提高该类患者的临床疗效。方法:对我院2001 ̄2004年发现的86例原发性肝癌合并门静脉癌栓的病例实施癌栓滋养动脉超选择性插管并以无水乙醇或无水乙醇+明胶海绵或无水乙醇+碘油实施栓塞,同时对主癌灶滋养动脉实施超选择性TACE或无水乙醇+碘油栓塞治疗。随访时间为2001 ̄2007年。结果:86例均成功实施癌栓及主癌灶滋养动脉超选择性栓塞;术后腹水消失或明显减少66.3%(57/86),腹水部分减少23.2%(20/86),腹水无明显减少10.5%(9/86);术后7 ̄10d,肝功能明显好转及好转71%(61/86)、肝功能变化不明显11.6%(10/86)、肝功能减低6%(5/86)、无显著肝功能减低或肝衰竭发生;术后3、6、12、24、36月生存率分别为97.7%(84/86)、95.3%(82/86)、72.1%(62/86)、47.7%(41/86)、16.3%(14/86)。结论:无水乙醇超选择性PVTT滋养动脉栓塞治疗可安全、有效阻断PVTT的血液供应而使癌栓坏死,同期进行主癌灶超选择性TAE或TACE治疗,可以明显提高患者的生活质量、延长生存期。 Objective:To retrospectively study the effect and curative effectiveness of ethanol in treating HCC with portal vein tumor thrombus (PVVT) through transcatheter fed arterial super selective infusion and super selective arterial embolization of main tumor,appraise the effect of ethanol in local treatment,in order to improve the clinical curative effects on the patients. Methods:The data of study from 86 cases of HCC with PVVT in our hospital between 2001-2004 year,to the fed artery of portal vein tumor thrombus super selective infusion ethanol or ethanol and gelfoam or ethanol and lipiodol,also through transcatheter super selective embolizing the fed arterys of main tumors including TACE or ethanol and lipiodol in 86 cases HCC. The course of observation was between 2001 and 2007year. Results:The super selective fed arterial embolization of PVVT and main tumors were successful in all cases;After treatment,ascites disappeared or obviously reduced in 66.3%(57/86) of cases,reduce in 23.2%(20/86),did not reduce in 10.5%(9/86);After 7-10d,hepatic function obviously improve or improve in 71%(61/86),did not obviously change in 11.6%(10/86),lowered in 6%(5/86),with no obvious lowering of hepatic function or hepatic function failure.The survival rates at 3,6,12,24,36months were 97.7%(84/86),95.5%(82/86),72.7%(62/86),47.7% (41/86) and 16.3%(14/86) respectively. Conclusion:The therapy of ethanol through catheter super selective PVVT fed arterial infusion is safe and effective,combined with super selective TAE or TACE to the fed artery of main tumor,could obviously improve the quality of life of the patients and could improve the survival rate.
出处 《重庆医科大学学报》 CAS CSCD 2008年第7期831-834,838,共5页 Journal of Chongqing Medical University
关键词 无水乙醇 肝癌 门静脉 癌栓 栓塞 Ethanol Hepatocellular carcinoma Portal vein Tumor thrombus Embolization
  • 相关文献

参考文献6

二级参考文献37

  • 1许荣德,周泽健,邵培坚,罗鹏飞,李伟科,栾建华,庄文行.经肝动脉栓塞化疗与激光消融术联合治疗原发性肝癌[J].中华放射学杂志,2004,38(6):587-591. 被引量:9
  • 2丛文铭,吴孟超.小肝细胞癌的临床病理特点:附93例分析[J].中华肿瘤杂志,1993,15(5):372-374. 被引量:35
  • 3李小明,胡国栋,陈孝平,吴人亮.无水乙醇碘油乳剂栓塞治疗原发性肝癌的病理研究[J].中华放射学杂志,1994,28(11):749-752. 被引量:25
  • 4Zhou J,J Cancer Res Clin Oncol,2000年,126卷,57页
  • 5Tanigawa N,Hepatology,1997年,26卷,1216页
  • 6Minagawa M,Makuuchi M, Takayama T, et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg,2001,233:379-384.
  • 7Burkhard K,Holger S,Sebstian F,et al. Detection of thrombosis in the portal venous system :comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angioraphy .Radiology ,2000,216:86-92.
  • 8Tublin ME, Dodd GD, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol, 1997,168:719-723.
  • 9Ohkubo T,Yamamoto J, Sugawara Y, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg ,2000,191:657-660.
  • 10Sasaki Y, Imaoka S, Kasugai H, et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer,1987,60:1194.

共引文献122

同被引文献31

  • 1刘崎,贾雨辰,贺佳,王振堂,田建明,叶华,陆建平,王飞,杨继金,孙飞,陈栋,林琳.肝癌合并门脉癌栓的化疗栓塞治疗[J].中华放射学杂志,1995,29(4):239-242. 被引量:82
  • 2刘阳晨,周绍兵,高飞,叶宏勋,赵莺,尹小祥.原发性肝癌介入治疗加三维适形放射治疗的疗效[J].现代肿瘤医学,2005,13(5):645-646. 被引量:11
  • 3刘池波,潘春琴,孙灵芬,梁勇.血清蛋白质谱模型在肝硬化诊断中的应用[J].中华检验医学杂志,2006,29(6):529-530. 被引量:19
  • 4郭旻,肖金成,赵晶.双介入法治疗肝癌门静脉癌栓[J].医药论坛杂志,2006,27(21):8-9. 被引量:4
  • 5陶正龙,季玉峰,金洪先,詹迎江,程永德.原发性肝癌合并门静脉癌栓的经动脉化疗栓塞治疗[J].介入放射学杂志,2006,15(11):667-669. 被引量:5
  • 6Mitsunobv M,Toyosake A, Oriyama T,et al. Mtrahepatic metases in hepatocellular carcinema:the hole of the portal vein as an efferent vessel. Clin Exp Metastasis, 1996,14 ( 7 ) :520-529.
  • 7Chung YH, Song Ⅱ Hart, Song BC, et al. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-a for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer, 2000,88 ( 12 ) : 1986- 1991.
  • 8Yamanaka W, Pkamoto E, Fujihara S ,et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venors stream during hepatic resection Cancer,1992,70(12) :2263-2267.
  • 9Fukuda S, Okuda K, Imamura M, et al. Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus : report of 19 cases. Surgery,, 2002,131 ( 3 ) : 300-310.
  • 10Mitsunohv M,Toyosake A,Oriyama T.et a1.Mtrahepatic metasesinhepatoedlular carcinema:the nole of the portal vein as all efer—ent vesse1[J].Clin Exp Metastasis,1996,14(7):520-529.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部